Form 4: Pfizer Executive Rady A. Johnson Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Executive Vice President Rady A. Johnson reports acquiring phantom stock units in Pfizer through the Supplemental Savings Plan.
Summary
- On October 10, 2024, Rady A. Johnson, an Executive Vice President at Pfizer Inc., reported acquiring 29 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
- The price per unit is $29.34.
- Following the transaction, Johnson directly owns 9,183 derivative securities.
- These units are settled in cash upon separation from service and can be transferred to an alternative investment account.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and potential alignment with company performance.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| 10/10/2024 | Date of transaction: Rady A. Johnson acquired phantom stock units. |
| 10/11/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.